In sliding 4.27%, RepliCel Life Sciences Inc. (CDX:RP:CA) was one of the worst performing stocks amongst TSX Venture Exchange-listed financial companies on February 16. After closing the previous session at $1.64, shares of RP:CA opened this morning at $1.57 and closed the day at $1.57. Throughout the day, about 45,178 shares changed hands, compared to an average 30-day volume of 46,973 for RepliCel Life Sciences Inc.. Shares moved as high as $1.64 and as low as $1.57 in today’s trading action.
The share depreciation gives the company a market capitalization of $25.68 million based upon 15.66 million shares outstanding.
In the past 52 weeks, shares of RepliCel Life Sciences Inc. have traded as low as $0.42 and as high as $2.3. Technical traders will take note that at $1.57, shares of RP:CA are trading above their 50-day moving average (MA) at $1.305 and above their 200-day MA at above $1.055. Technical analysts pay close attention to these key moving averages because they often serve as technical support and resistance levels and because a move beneath or holding under them is typically regarded as bearish.
Who is $Replicel Lif?
RepliCel Life Sciences Inc is a clinical stage bio-pharmaceutical company engaged in developing autologous cell therapies that treat functional cellular deficits. The Company's products include RCT-01, RCS-01 and RCH-01. The company is led by its CEO R. Lee Buckler from its headquarters at 401 West Georgia Street.
For more information on Replicel Lif and other companies trading on the TSX Venture Exchange, as well as other Canadian and American stock exchanges, or to be considered for contributing content for our distribution network, visit FinancialPress.com today.
All data provided by QuoteMedia, with stock data accurate as of 4:00 PM ET. FinancialPress.com is not responsible for inaccuracies in third-party supplied information.
About the TSX Venture Exchange
Owned and operated by the TMX Group, the TSX Venture Exchange is a public venture capital marketplace for emerging companies. It is headquartered in Calgary, Alberta, Canada with offices in Toronto, Vancouver and Montreal. All trading on the exchange is done electronically. Originally established in 1999, the “Venture,” as it is often shortened, was previously known as the Canadian Venture Exchange, but renamed in 2001 subsequent to the TSX Group (now known as the TMX Group) purchasing it.
FinancialPress.com is a leading publisher of market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique opportunities for industry partnerships, corporate communications, market exposure and investment. A complete disclaimer can be viewed here. If you like this article, you can read more at FinancialPress.com
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of FinancialPress.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://financialpress.com/legal-disclaimer/.